Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-090199

Chief Technology Officer acquired 5,353 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Tyagarajan Seshu Chief Technology Officer 2025-06-25 Grant or award +5,353 $4.67 $24,999 90,865 D
Loading xslF345X05/ownership.xml…